Results 131 to 140 of about 2,763,581 (350)

Chronic urticaria associated with malignancies: A review article

open access: yesChronic Diseases Journal, 2019
BACKGROUND: Chronic urticaria is a cutaneous disorder defined by the presence of hives and flare for over six weeks. Etiology of chronic urticaria is not clear in 80 to 90 percent of patients.
Javad Ghaffari
doaj   +1 more source

An Integrated Method to Evaluate the Treatment Efficacy and Immunogenicity of B‐Cell Acute Lymphoblastic Leukemia Therapeutic Enzyme Formulations

open access: yesSmall Methods, EarlyView.
This work presents an integrated set of methods to evaluate the efficacy of asparaginase formulations against B‐cell Acute Lymphoblastic Leukemia (ALL) in mice, including the establishment of an ALL murine model, an amino acid depletion study using high‐performance liquid chromatography (HPLC), and comprehensive assessment of antibody production ...
Julien Santelli   +6 more
wiley   +1 more source

A Proposal to Center Relevance in Applied Linguistics Research: The Relevance‐to‐Practice (RTP) Framework

open access: yesTESOL Quarterly, EarlyView.
Abstract Considering applied linguistics as a problem‐centered discipline, we address an enduring challenge in the field: the need to ensure that research provides findings that can contribute to solving everyday challenges faced by language practitioners.
Hyun‐Bin Hwang, Matthew D. Coss
wiley   +1 more source

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki   +24 more
wiley   +1 more source

Successful and Safe Treatment of Chronic Spontaneous Urticaria with Omalizumab in a Woman during Two Consecutive Pregnancies

open access: yesCase Reports in Medicine, 2015
Chronic spontaneous urticaria is an itching skin disease characterised by wheals, angioedema, or both present for more than six weeks. Omalizumab is a humanized anti-IgE monoclonal antibody recently approved for treatment of chronic urticaria.
Misbah Nasheela Ghazanfar   +1 more
doaj   +1 more source

Chronic urticaria following acute hepatitis A: Figure 1 [PDF]

open access: bronze, 2012
Paul Griffin   +3 more
openalex   +1 more source

Treatment Satisfaction, Efficacy, and Safety of Delgocitinib Ointment Following Switch From Topical Corticosteroids for Trunk and Extremity Rash in Atopic Dermatitis

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Atopic dermatitis (AD) is a chronic inflammatory disease characterized by recurrent remissions and relapses. Topical anti‐inflammatory steroids are commonly used for treatment, but their long‐term use poses concerns because of potential side effects. Delgocitinib ointment, a Janus kinase inhibitor, has demonstrated efficacy in several clinical
Masatoshi Abe   +5 more
wiley   +1 more source

Streptococcal tonsillitis as a cause of urticaria Tonsillitis and urticaria [PDF]

open access: yes, 2011
BACKGROUND: The primary role of infections in chronic urticaria (CU) is controversial. We hypothesised that streptococcal tonsillitis (ST) could be a primary cause of CU or acute recurrent urticaria (ARU).
Calado, G   +6 more
core  

Development and Validation of the Japanese Version of the Hyperhidrosis Quality of Life Index

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Hyperhidrosis decreases an individual's quality of life (QOL). The Hyperhidrosis Quality of Life Index (HidroQoL) measures the impact of hyperhidrosis on QOL and has established reliability and validity. However, a Japanese version does not exist.
Sayaka Ogawa   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy